Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Novartis, U.S. Partner Plan Remote Trials to Boost Participation

Reuters Staff  |  March 8, 2018

ZURICH (Reuters)—Novartis plans up to 10 clinical trials over three years using a U.S. partner’s mobile technology to help free patients from burdensome hospital trips as the Swiss drugmaker aims to boost study participation and cut costs. Novartis said on Wednesday it would work with Science 37, a California-based company that provides technology including smart…

Filed under:Uncategorized Tagged with:Novartisremote trialsScience 37video-based telemedicine

Back to the Future: Spotlight on ACR Past President Dr. Herbert Kaplan

Aileen Lorenzo Pangan, MD  |  March 7, 2018

We are sad to report that Dr. Kaplan passed away on Saturday, June 23. We are reposting this story now to celebrate his life.

Filed under:From the CollegeProfiles Tagged with:KaplanProfiles

FDA Update: Possible Heart Risks with Clarithromycin; Apadaz Receives FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  March 7, 2018

After reviewing a 10-year study, the FDA cautions that prescribing clarithromycin to patients with heart disease increases the risk of heart problems or death…

Filed under:Drug Updates Tagged with:acute painantibioticsApadazclarithromycinHeart Disease

Inflammation in OA: Signs & Treatment Opportunities

Carina Stanton  |  March 6, 2018

The demonstrated connection between persistent effusion-synovitis and cartilage damage in certain osteoarthritis (OA) patients has implications for targeted treatment that updates previous OA treatment parameters…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:cartilagecartilage lossinflammationOsteoarthritissynovitissynovitis effusion

Healthy Diet Linked to Lower Hip Fracture Risk in U.S. Women

Mary Gillis  |  March 4, 2018

(Reuters Health)—Eating an overall healthy diet is tied to a lower risk of hip fracture among women over age 50, a U.S. study suggests. Researchers analyzed decades’ worth of dietary and health data for more than 100,000 U.S. men and women. They found that women who scored highest on the American Healthy Eating Index-2010 (AHEI)…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:DietFractureshealthy eatinghip fracturehip fracture riskOsteoporosispostmenopausal womenWomen

Diclofenac Patch, Piroxicam Most Effective Topical NSAIDs for Osteoarthritis

Reuters Staff  |  February 28, 2018

NEW YORK (Reuters Health)—Diclofenac patches appear to be the most effective topical nonsteroidal anti-inflammatory drug (NSAID) for osteoarthritis (OA), according to a new systematic review and network meta-analysis. “Topical NSAIDs were effective and safe for OA,” Dr. Weiya Zhang of the University of Nottingham and City Hospital in the UK and colleagues write. “However, confirmation…

Filed under:Drug UpdatesOsteoarthritis and Bone Disorders Tagged with:diclofenac patchosteoarthritis (OA)piroxicamtopical NSAIDs

Secukinumab Promising for Sustained Improvements in Palmoplantar & Nail Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  February 28, 2018

In clinical trials, secukinumab proved safe and effective as a long-term treatment for both palmoplantar and nail psoriasis…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:nail psoriasisnailspalmoplantar psoriasisPsoriasissecukinumab

Blacks in U.S. Lose Quality of Life Due to Fewer Knee Replacements

Lisa Rapaport  |  February 22, 2018

(Reuters Health)—Black people with knee osteoarthritis may have a worse quality of life than white patients in part because they’re less likely to be offered knee replacement surgery or to get the procedure when it’s recommended, a U.S. study suggests. Knee replacement surgery has the potential to greatly relieve suffering from severe joint pain that…

Filed under:Osteoarthritis and Bone Disorders Tagged with:Elena Losinaknee osteoarthritisknee replacement surgeryquality of life

Ferumoxytol Injection Receives New Indication, & Application for GP2017 Moves Ahead

Michele B. Kaufman, PharmD, BCGP  |  February 20, 2018

The FDA recently expanded the indications for ferumoxytol injections to include the treatment of adults with iron-deficiency anemia…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabanemiaBiosimilarsFDAFDA approvalferumoxytolferumoxytol injectionGP2017Humirairon-deficiency anemiaU.S. Food and Drug Administration (FDA)

Rheumatology Awards, Appointments & Announcements for Feb. 2018

Ann-Marie Lindstrom  |  February 18, 2018

ARHP Member Named to AOTF Board of Trustees (2018–20) Nancy A. Baker, ScD, MPH, OTR, recently took on a new role, joining the American Occupational Therapy Foundation’s (AOTF’s) Board of Trustees. The AOTF is a charitable organization with a mission to support scientific and educational programming for occupational therapy. It provides most of the grants…

Filed under:Profiles Tagged with:Anna KhananianAwardsKaren CostenbaderLupus FoundationMovers & ShakersNancy BakerNaseem Alexa JahdiStevan Gibson

  • « Previous Page
  • 1
  • …
  • 159
  • 160
  • 161
  • 162
  • 163
  • …
  • 324
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences